POSSIBLE ROLE OF PROSTACYCLIN SYNTHASE IN ALTERED PROSTACYCLIN GENERATION IN DOCA-SALT HYPERTENSIVE RATS

被引:4
作者
UEHARA, Y
NUMABE, A
TAKADA, S
HIRAWA, N
NAGATA, T
ISHIMITSU, T
SUGIMOTO, T
YAGI, S
机构
[1] 2nd Department of Internal Medicine, University of Tokyo
[2] Department of Medicine, Division of Hypertension and Cardiorenal Disease, Dokkyo University School of Medicine, Tochigi
[3] The 2nd Department of Medicine, Yokohama City University, Yokohama
关键词
PROSTACYCLIN SYNTHASE; DOCA-SALT RATS; PROSTACYCLIN; PHOSPHOLIPASE; VASCULAR WALL;
D O I
10.1093/ajh/4.8.667
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Prostacyclin (PGI2) synthase is one of the key enzymes for vasodepressor PGI2 biosynthesis in the vascular wall. In this study, we attempted to define the alterations in PGI2 synthase and its role in the PGI2 generation in the vascular wall of deoxycorticosterone acetate (DOCA)-salt rats. The PGI2-generating capacity was enhanced significantly when DOCA-salt rats established hypertension, whereas the generation of other arachidonate metabolites, eg, PGE2, PGF2-alpha, and thromboxane, was unaltered. Moreover, the increase in PGI2 generation was associated with an increase in PGI2 synthase activity in the vascular wall. Indeed, the averaged PGI2 generating capacity was closely correlated to the averaged PGI2 synthase activity in DOCA-salt hypertensive rats and three lines of control rats. Incontrast, phospholipase C and phospholipase A2, both of which liberate arachidonate for PGI2 synthesis, were rather lowered in DOCA-salt hypertensive rats. These data clearly indicate that vascular PGI2 generation is increased in the development of DOCA-salt hypertension and that PGI2 synthase is mainly responsible for this enhancement. The increased PGI2 synthase may be relevant to the blood pressure elevation and is expected to have beneficial effects on the vascular protection in hypertension.
引用
收藏
页码:667 / 673
页数:7
相关论文
共 22 条
[1]  
Subbiah M., Bale L.K., Kottke B.A., Deitemeyer D., Regional aortic differences in atherosclerotic-susceptibility: Changes in prostaglandin biosynthesis and cholesterol accumulation in response to desoxycorticosterone (DOCA)-salt induced hypertension, Virchow Arch (Cell Pathol), 37, pp. 309-315, (1981)
[2]  
Uehara Y., Ishimitsu T., Ishii M., Sugimoto T., Prostacyclin synthase and phospholipase in the vascular wall of experimental hypertensive rats, Prostaglandins, 34, pp. 423-432, (1987)
[3]  
Uehara Y., Ishimitsu T., Kimura K., Et al., Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats, Prostaglandins, 36, pp. 847-857, (1988)
[4]  
Ishimitsu T., Uehara Y., Ishii M., Et al., Roles of endogenous vasodepressor prostaglandins in vascular smooth muscle cells growth in spontaneously hypertensive rats, Jpn Cir J, 54, pp. 1546-1553, (1990)
[5]  
Bell R.L., Kennedy D.A., Stanfors N., Majerus P.W., Diglyceride lipase: A pathway for arachidonate release from human platelet, Proc Natl Acad Sei USA, 76, pp. 3238-3241, (1979)
[6]  
Lapentina E.G., Phospholipases. Ann Rep Med Chem, 19, pp. 213-221, (1984)
[7]  
Uehara Y., Ishimitsu T., Iwai J., Et al., Relevance of vascular PGI2 synthase to vascular prostacyclin production in Dahl rats susceptible to salt-induced hypertension, Am J Hypertens, 3, pp. 313-316, (1990)
[8]  
Gryglewski R.J., Botting R.M., Vane J.R., Mediators produced by endothelial cells, Hypertension, 12, pp. 530-548, (1988)
[9]  
Uehara Y., Tobian L., Iwai J., Et al., Alterations of vascular prostacyclin and thromboxane A2 in Dahl genetical strain susceptible to salt-induced hypertension, Prostaglandins, 33, pp. 727-738, (1987)
[10]  
Uehara Y., Ishii M., Ishimitsu T., Sugimoto T., Enhanced phospholipase C activity in vascular wall of spontaneously hypertensive rats, Hypertension, 11, pp. 28-33, (1988)